ReWalk Robotics Ltd. (LFWD)
1.75
-0.12 (-6.42%)
At close: Mar 21, 2025, 3:59 PM
1.74
-0.10%
After-hours: Mar 21, 2025, 07:00 PM EDT
-6.42% (1D)
| Bid | 1.7 |
| Market Cap | 18.55M |
| Revenue (ttm) | 30.97M |
| Net Income (ttm) | -34.93M |
| EPS (ttm) | -3.33 |
| PE Ratio (ttm) | -0.52 |
| Forward PE | -1.57 |
| Analyst | Buy |
| Ask | 1.78 |
| Volume | 437,548 |
| Avg. Volume (20D) | 2,668,486 |
| Open | 1.87 |
| Previous Close | 1.87 |
| Day's Range | 1.69 - 1.84 |
| 52-Week Range | 1.25 - 6.00 |
| Beta | 1.74 |
About LFWD
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabil...
Industry Medical - Devices
Sector Healthcare
IPO Date Sep 12, 2014
Employees 80
Stock Exchange NASDAQ
Ticker Symbol LFWD
Website https://www.rewalk.com
Analyst Forecast
According to 4 analyst ratings, the average rating for LFWD stock is "Buy." The 12-month stock price forecast is $11.5, which is an increase of 559.03% from the latest price.
Stock ForecastsNext Earnings Release
ReWalk Robotics Ltd. is scheduled to release its earnings on May 14, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+8.84%
Lifeward shares are trading higher after the compa...
Unlock content with
Pro Subscription
1 month ago
+33.57%
Lifeward shares are trading higher after Laidlaw & Co. initiated coverage on the stock with a Buy rating and announced a price target of $10.
